Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,484 | 237,876 | 167,662 | 114,960 | 182,332 |
| Marketable Securities | 295,910 | 221,400 | 94,227 | 158,616 | 120,061 |
| Receivables | 33,632 | 7,493 | 7,940 | 12,141 | 11,010 |
| Inventories | N/A | N/A | N/A | 2,128 | 3,254 |
| TOTAL | $489,163 | $469,984 | $273,749 | $291,056 | $319,647 |
| Non-Current Assets | |||||
| PPE Net | 47,781 | 49,353 | 51,035 | 53,854 | 57,421 |
| Investments And Advances | 60,981 | 61,983 | 27,708 | 30,507 | 21,836 |
| Other Non-Current Assets | 3,506 | 3,770 | 2,694 | 2,915 | 3,185 |
| TOTAL | $112,268 | $115,106 | $81,437 | $87,276 | $82,442 |
| Total Assets | $601,431 | $585,090 | $355,186 | $378,332 | $402,089 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,081 | 21,471 | 19,054 | 16,466 | 18,383 |
| TOTAL | $83,604 | $45,014 | $32,698 | $31,508 | $33,667 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 |
| Deferred Revenues | 63,523 | 23,543 | 13,644 | 15,042 | 15,284 |
| TOTAL | $321,138 | $323,452 | $260,015 | $263,057 | $266,099 |
| Total Liabilities | $404,742 | $368,466 | $292,713 | $294,565 | $299,766 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,959 | 65,631 | 57,451 | 56,972 | 56,951 |
| Common Shares | 65 | 65 | 57 | 57 | 57 |
| Retained earnings | -717,534 | -687,617 | -656,646 | -629,236 | -605,660 |
| Other shareholders' equity | -159 | -231 | -95 | -473 | -371 |
| TOTAL | $196,689 | $216,624 | $62,473 | $83,767 | $102,323 |
| Total Liabilities And Equity | $601,431 | $585,090 | $355,186 | $378,332 | $402,089 |